| Kelly A Zilli | |
|
2421 Monroe St Ste 202, Dearborn, MI 48124-3043 | |
| (313) 562-4485 | |
| (313) 562-0447 |
| Full Name | Kelly A Zilli |
|---|---|
| Type | Facility |
| Speciality | Audiologist |
| Location | 2421 Monroe St Ste 202, Dearborn, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457419541 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kelly A Zilli 2421 Monroe Street, Suite 202, Dearborn, MI 48124 Ph: (313) 562-4485 | Kelly A Zilli 2421 Monroe St Ste 202, Dearborn, MI 48124-3043 Ph: (313) 562-4485 |
News Archive
The researchers examined the effect of the COVID-19 vaccination campaign on 250 different Israeli cities with distinct demographic and ethnic characteristics.
Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that its affiliate VGX International Inc. has received approval in Korea to begin a Phase I clinical trial in healthy volunteers for Inovio's SynCon™ preventive DNA vaccine (VGX-3400) targeting H5N1 avian influenza.
Colombian infants exposed to Zika virus in the womb showed neurodevelopmental delays as toddlers, despite having "normal" brain imaging and head circumference at birth, a finding that underscores the importance of long-term neurodevelopmental follow-up for Zika-exposed infants, according to a study published online Jan. 6, 2020, in JAMA Pediatrics.
United Therapeutics Corporation (Nasdaq: UTHR) announced today that its Board of Directors has approved and declared a stock split. The stock split will be effected in the form of a stock dividend, in which one share of United Therapeutics common stock will be distributed for each share of common stock issued and outstanding (or held in treasury) at the close of business on the record date, September 14, 2009.
Researchers at The Pennsylvania State University College of Medicine, led by Dr. Ian S. Zagon, have discovered that a novel biological pathway, the OGF-OGFr axis, can be modulated in human triple-negative breast cancer cells to inhibit proliferation. According to BreastCancer.org 1 in 8 women in the U.S. will develop invasive breast cancer and more than 39,000 deaths occur annually.
› Verified 1 days ago
Serafina Romano, Audiologist Medicare: Accepting Medicare Assignments Practice Location: 22731 Newman St, Ste 120, Dearborn, MI 48124 Phone: 313-582-8852 | |
Mrs. Kelly Ann Zilli, AUD DOCTOR OF AUDIOL Audiologist Medicare: Medicare Enrolled Practice Location: 2421 Monroe St, Ste 202, Dearborn, MI 48124 Phone: 313-562-4485 Fax: 313-562-0447 | |
Midwest Health Center Pc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 5050 Schaefer Rd, Dearborn, MI 48126 Phone: 313-581-2600 Fax: 313-581-0228 | |
Doryce Iverson, Audiologist Medicare: Accepting Medicare Assignments Practice Location: 2421 Monroe St, 202, Dearborn, MI 48124 Phone: 313-562-4485 | |
Colleen M Martin, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 5050 Schaefer Rd, Dearborn, MI 48126 Phone: 313-581-2600 Fax: 313-581-0228 | |
Dr. Eileen Marie Bessega, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 1937 Golfview Dr, Dearborn, MI 48128 Phone: 313-530-9774 | |
Dr. Tracy Ann Rudd, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 18101 Oakwood Blvd, Suite 402, Dearborn, MI 48124 Phone: 313-253-0800 Fax: 313-577-8555 |